Innate Pharma SA logo

Innate Pharma SA - Class A

NEW
LTS:0EVI (France)   Class A
€ 1.837 -0.029 (-1.55%) Aug 17
At Loss
Market Cap:
€ 169.59M ($ 196.34M)
Enterprise V:
€ 157.85M ($ 182.75M)
Volume:
22.29K
Avg Vol (2M):
9.17K
Trade In:
Volume:
22.29K
At Loss

Innate Pharma SA (LTS:0EVI) Dividend

Innate Pharma SA (LTS:0EVI) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -5.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: LTS:0EVI Dividend

Does Innate Pharma SA (LTS:0EVI) pay a dividend?

Innate Pharma SA (LTS:0EVI) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Innate Pharma SA pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Innate Pharma SA has returned capital to shareholders via buybacks at a rate of -5.6% over the past 3 years.

What are dividend-paying alternatives to Innate Pharma SA?

For dividend-paying alternatives in Innate Pharma SA's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.